Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.51 USD | +0.49% | -2.08% | -0.37% |
Jan. 15 | HP Inc Announces Management Changes | CI |
Jan. 13 | Bernstein Adjusts Price Target on HP $34 From $32, Keeps Market Perform Rating | MT |
Fiscal Period: October | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 56.64B | 63.49B | 62.98B | 53.72B | 53.56B | |||||
Finance Div. Revenues | - | - | - | - | - | |||||
Total Revenues | 56.64B | 63.49B | 62.98B | 53.72B | 53.56B | |||||
Cost of Goods Sold, Total | 46.2B | 50.07B | 50.65B | 42.21B | 41.74B | |||||
Interest Expense - Finance Division | - | - | - | - | - | |||||
Gross Profit | 10.44B | 13.42B | 12.34B | 11.51B | 11.82B | |||||
Selling General & Admin Expenses, Total | 4.88B | 5.54B | 5.26B | 5.36B | 5.65B | |||||
R&D Expenses | 1.48B | 1.91B | 1.59B | 1.58B | 1.64B | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 113M | 154M | 228M | 350M | 318M | |||||
Other Operating Expenses, Total | 6.47B | 7.61B | 7.08B | 7.28B | 7.6B | |||||
Operating Income | 3.96B | 5.81B | 5.25B | 4.22B | 4.21B | |||||
Interest Expense, Total | -239M | -254M | -359M | -548M | -452M | |||||
Interest And Investment Income | 40M | 31M | 46M | 67M | 78M | |||||
Net Interest Expenses | -199M | -223M | -313M | -481M | -374M | |||||
Income (Loss) On Equity Invest. | - | - | - | - | - | |||||
Currency Exchange Gains (Loss) | 40M | -65M | 41M | -65M | 44M | |||||
Other Non Operating Income (Expenses) | -13M | 13M | 37M | 58M | -218M | |||||
EBT, Excl. Unusual Items | 3.79B | 5.54B | 5.02B | 3.74B | 3.67B | |||||
Restructuring Charges | -401M | -223M | -231M | -583M | -233M | |||||
Merger & Related Restructuring Charges | -16M | -68M | -318M | -240M | -83M | |||||
Asset Writedown | - | - | - | - | - | |||||
Legal Settlements | - | 2.3B | - | - | - | |||||
Other Unusual Items | -145M | -38M | -25M | 24M | -71M | |||||
EBT, Incl. Unusual Items | 3.23B | 7.51B | 4.44B | 2.94B | 3.28B | |||||
Income Tax Expense | 387M | 1.01B | 1.24B | -326M | 504M | |||||
Earnings From Continuing Operations | 2.84B | 6.5B | 3.2B | 3.26B | 2.78B | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | 2.84B | 6.5B | 3.2B | 3.26B | 2.78B | |||||
Net Income - (IS) | 2.84B | 6.5B | 3.2B | 3.26B | 2.78B | |||||
Net Income to Common Incl Extra Items | 2.84B | 6.5B | 3.2B | 3.26B | 2.78B | |||||
Net Income to Common Excl. Extra Items | 2.84B | 6.5B | 3.2B | 3.26B | 2.78B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 2.01 | 5.38 | 3.09 | 3.29 | 2.83 | |||||
Basic EPS - Continuing Operations | 2.01 | 5.38 | 3.09 | 3.29 | 2.83 | |||||
Basic Weighted Average Shares Outstanding | 1.41B | 1.21B | 1.04B | 992M | 979M | |||||
Net EPS - Diluted | 2 | 5.33 | 3.05 | 3.26 | 2.81 | |||||
Diluted EPS - Continuing Operations | 2 | 5.33 | 3.05 | 3.26 | 2.81 | |||||
Diluted Weighted Average Shares Outstanding | 1.42B | 1.22B | 1.05B | 1B | 989M | |||||
Normalized Basic EPS | 1.68 | 2.86 | 3.02 | 2.35 | 2.34 | |||||
Normalized Diluted EPS | 1.67 | 2.84 | 2.99 | 2.34 | 2.32 | |||||
Dividend Per Share | 0.7 | 0.78 | 1 | 1.05 | 1.1 | |||||
Payout Ratio | 35.06 | 14.42 | 32.38 | 31.78 | 38.74 | |||||
American Depositary Receipts Ratio (ADR) | 1 | 1 | 1 | 1 | 1 | |||||
Supplemental Items | ||||||||||
EBITDA | 4.75B | 6.6B | 6.03B | 5.07B | 5.04B | |||||
EBITA | 4.08B | 5.96B | 5.48B | 4.57B | 4.53B | |||||
EBIT | 3.96B | 5.81B | 5.25B | 4.22B | 4.21B | |||||
EBITDAR | 5.1B | 6.93B | 6.36B | 5.41B | 5.38B | |||||
Total Revenues (As Reported) | - | - | - | - | 53.56B | |||||
Effective Tax Rate - (Ratio) | 11.98 | 13.42 | 27.88 | -11.1 | 15.37 | |||||
Current Domestic Taxes | -1M | 1.2B | 327M | 268M | 278M | |||||
Current Foreign Taxes | 319M | 420M | 341M | 337M | 357M | |||||
Total Current Taxes | 318M | 1.62B | 668M | 605M | 635M | |||||
Deferred Domestic Taxes | -95M | -410M | 70M | -626M | 62M | |||||
Deferred Foreign Taxes | 164M | -197M | 500M | -305M | -193M | |||||
Total Deferred Taxes | 69M | -607M | 570M | -931M | -131M | |||||
Normalized Net Income | 2.37B | 3.46B | 3.13B | 2.34B | 2.29B | |||||
Non-Cash Pension Expense | 9M | -154M | -117M | 79M | 12M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 578M | 829M | 696M | 611M | 628M | |||||
Research And Development Expense From Footnotes | 1.48B | 1.91B | 1.59B | 1.58B | 1.64B | |||||
Net Rental Expense, Total | 344M | 336M | 332M | 336M | 336M | |||||
Imputed Operating Lease Interest Expense | 105M | 84.28M | 90.06M | 127M | 112M | |||||
Imputed Operating Lease Depreciation | 239M | 252M | 242M | 209M | 224M | |||||
Stock-Based Comp., Other (Total) | 278M | 330M | 343M | 438M | 452M | |||||
Total Stock-Based Compensation | 278M | 330M | 343M | 438M | 452M |